查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945466

2026年全球快速侧向流动免疫检测（LFIA）检测市场报告

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，基于侧向流动免疫检测（LFIA）的快速检测市场规模持续扩大，预计将以2.0%的复合年增长率成长，从2025年的71.7亿美元成长到2026年的73.1亿美元。过去几年的成长可归因于快速感染疾病筛检的扩展、怀孕和不孕症检测的日益普及、照护现场诊断的发展、低成本快速检测的广泛应用以及公共卫生筛检措施的增加。

基于侧向流动免疫检测（LFIAT）的快速检测市场规模预计将在未来几年稳步增长，到2030年将达到86.7亿美元，复合年增长率（CAGR）为4.3%。成长要素：对基于快速免疫检测的检测需求不断增长、家用LFIAT试剂盒的普及率不断提高、多重检测方法的应用范围不断扩大、传染病检查的应用范围不断扩大以及对用户友好型检测设计日益重视。

慢性病盛行率的上升预计将推动基于侧向流动免疫检测(LFIA) 的快速检测市场成长。慢性病（也称为非传染性疾病：NCDs）是指长期、持续的健康问题，通常会伴随人的一生。基于 LFIA 的快速检测能够实现早期发现、就地检验、快速出结果、持续监测，并降低与慢性病管理相关的医疗保健成本。这些检测因其快速且便捷的检测结果而备受推崇，使医护人员和患者能够及时做出有关治疗和生活方式调整的决策。例如，根据英国政府机构国家医疗服务体系（NHS）发布的数据，截至2024年6月，在全科医生处登记的3,615,330名患者在2023年被诊断患有非糖尿病性高血糖或糖尿病前期，比2022年的3,065,825例增加了18%。因此，慢性病盛行率的上升正在推动基于液相界面分析（LFIA）的快速检测市场的扩张。

市场参与企业正致力于研发先进的诊断技术，以提高效率和患者照护。例如，Integrated Health Solutions 正在整合医疗服务、技术和数据，以增强跨医疗平台的工作流程和协作。 2024 年 6 月，总部位于瑞士的製药公司罗氏 (F. Hoffmann-La Roche AG) 发布了其 Cobas Pro 整合解决方案的分析单元。该系统使用样本供应单元时每小时可处理多达 1000 个检体，使用离子选择性电极 (ISE) 分析时每小时可处理 900 个测试，而使用 Cobas C 503 临床化学单元时每小时可处理 1000 个测试，从而提高检查室效率和患者照护水平。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球侧向流动免疫检测（LFIA）快速检测市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧与自主智能
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网 (IoT)、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 对基于快速免疫检测的检测方法的需求不断增长
    • 扩大家用LFIa套件的推广
    • 多重检测分析方法的广泛应用
    • 扩大传染病检查应用范围
    • 越来越重视使用者友善的测试设计

第五章 终端用户产业市场分析

  • 医院和诊所
  • 诊断检查室
  • 居家照护用户
  • 公共卫生机构
  • 製药和生物技术公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球侧向流动免疫检测（LFIA）快速检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球侧向层析免疫检测（LFIA）快速检测市场规模、对比及成长率分析
  • 全球侧向流动免疫检测（LFIA）快速检测市场表现：规模与成长，2020-2025年
  • 全球侧向流动免疫检测(LFIA) 快速检测市场预测：规模与成长，2025-2030 年，2035 年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 透过技术
  • 竞争性检测、夹心检测和多重检测
  • 透过使用
  • 感染疾病、怀孕和不孕症治疗、毒理学、心臟标记和胆固醇检测以及其他用途
  • 最终用户
  • 医院/诊所、诊断检查室、居家医疗和其他终端用户
  • 按类型细分：竞争性侦测
  • 直接竞争性检测，间接竞争性检测
  • 按类型细分：夹心法检测
  • 一步法夹心法检测，两步骤法夹心法检测
  • 按类型细分：多重侦测分析
  • 多分析物检测，同时检测多种标靶

第十章 区域与国家分析

  • 全球快速侧向层析免疫检测(LFIA) 检测市场：区域分析、绩效及预测（2020-2025 年、2025-2030 年预测、2035 年预测）
  • 全球快速侧向层析免疫检测(LFIA) 检测市场：国家/地区、性能和预测，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 侧向流动免疫检测（LFIA）快速侦测市场：竞争格局与市场份额，2024年
  • 快速侧向层析免疫检测(LFIA) 检测市场：公司评估矩阵
  • 快速侧向层析免疫检测（LFIA）检测市场：公司概况
    • Abbott Laboratories
    • F. Hoffmann-La Roche
    • Quidel Corporation
    • Becton, Dickinson and Company
    • Danaher Corporation

第37章：其他领先和创新企业

  • Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience（R）Immunoassay Kits, FyoniBio/Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 快速侧向流动免疫检测(LFIA) 检测市场 2030：提供新机会的国家
  • 快速侧向流动免疫检测(LFIA) 检测市场 2030 年展望：新兴细分市场机会
  • 快速侧向流动免疫检测(LFIA) 检测市场 2030 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MLFIL02_G26Q1

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

Tariffs are influencing the LFIA based rapid test market by increasing costs of imported antibodies, membranes, nanoparticles, reader components, and packaging materials. Healthcare systems and diagnostic manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on large-scale test production. These tariffs are increasing unit costs and affecting affordability. At the same time, they are driving domestic manufacturing, local sourcing of assay components, and innovation in cost-efficient rapid test formats.

The lateral flow immunoassay (lfia) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (lfia) based rapid test market statistics, including lateral flow immunoassay (lfia) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (lfia) based rapid test market share, detailed lateral flow immunoassay (lfia) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (lfia) based rapid test industry. This lateral flow immunoassay (lfia) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (lfia) based rapid test market size has grown steadily in recent years. It will grow from $7.17 billion in 2025 to $7.31 billion in 2026 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to expansion of rapid infectious disease screening, increasing adoption of pregnancy and fertility tests, growth of point-of-care diagnostics, availability of low-cost rapid tests, rising public health screening initiatives.

The lateral flow immunoassay (lfia) based rapid test market size is expected to see steady growth in the next few years. It will grow to $8.67 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing investments in decentralized diagnostics, expansion of self-testing applications, growing demand for rapid cardiac and toxicology tests, rising integration with digital health platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing demand for rapid immunoassay-based testing, rising adoption of home-use lfia kits, growing use of multiplex detection assays, expansion of infectious disease testing applications, enhanced focus on user-friendly test design.

The rising prevalence of chronic diseases is expected to drive growth in the lateral flow immunoassay (LFIA) based rapid test market. Chronic diseases, also referred to as non-communicable diseases (NCDs), are long-term health conditions that persist over extended periods, often throughout a person's lifetime. LFIA-based rapid tests facilitate early detection, point-of-care testing, rapid results, ongoing monitoring, and reduced healthcare costs associated with chronic disease management. These tests are valued for providing quick and accessible results, allowing healthcare professionals and patients to make timely decisions regarding treatment and lifestyle adjustments. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported that 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. As a result, the growing prevalence of chronic diseases is supporting the expansion of the LFIA-based rapid test market.

Companies in the market are focusing on advanced diagnostic technologies to improve efficiency and patient care. Integrated Health Solutions, for instance, connect healthcare services, technologies, and data to enhance workflow and collaboration across healthcare platforms. In June 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, launched analytical units for its Cobas Pro integrated solutions. The system can process up to 1,000 samples per hour using its sample supply unit and perform up to 900 tests per hour for ion-selective electrode (ISE) analysis and 1,000 tests per hour on the Cobas C 503 unit for clinical chemistry, streamlining laboratory operations and improving patient care.

In August 2023, Danaher Corporation, a US-based medical products company, acquired Abcam plc for $5.7 billion. This acquisition aligns with Danaher's strategy to expand its life sciences business and support clients in addressing major healthcare challenges. Abcam plc, a UK-based biotechnology company, specializes in the manufacture of LFIA-based rapid tests, and the acquisition is expected to enhance value for shareholders while delivering improved outcomes for employees and clients.

Major companies operating in the lateral flow immunoassay (lfia) based rapid test market are Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., Hologic Inc., LTEK Co. Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, 3a Diagnostics, Roche Holding AG, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lateral flow immunoassay (lfia) based rapid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lateral flow immunoassay (lfia) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technique: Competitive Assay; Sandwich Assay; Multiplex Detection Assay
  • 2) By Application: Infectious Disease; Pregnancy And Fertility; Toxicology; Cardiac Marker And Cholesterol Testing; Other Applications
  • 3) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Home Care; Other End Users
  • Subsegments:
  • 1) By Competitive Assay: Direct Competitive Assays; Indirect Competitive Assays
  • 2) By Sandwich Assay: Single-step Sandwich Assays; Two-step Sandwich Assays
  • 3) By Multiplex Detection Assay: Multi-analyte Assays; Simultaneous Detection Of Various Targets
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; PerkinElmer Inc.; Hologic Inc.; LTEK Co. Ltd.; JOYSBIO Biotechnology; Jiangsu Medomics Medical Technologies; Diagnocure; Ubio Biotechnology Systems; Elabscience(R) Immunoassay Kits; FyoniBio / Glycotope GmbH; Atomo Diagnostics Limited; INDICAL Bioscience; Lionex Gmbh; BIOMED Labordiagnostik GmbH; EKF Diagnostics; Launch Diagnostics; Diagnostic Instruments Ltd; Qiagen N.V.; Merck KGaA; 3a Diagnostics; Roche Holding AG; Biomaxima; SensDx; Vitrosens Biotechnology; Bioeasy Biotechnology; Fujirebio; Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; CTK Biotech
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
    • 4.1.5 Industry 4.0 And Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Demand For Rapid Immunoassay-Based Testing
    • 4.2.2 Rising Adoption Of Home-Use Lfia Kits
    • 4.2.3 Growing Use Of Multiplex Detection Assays
    • 4.2.4 Expansion Of Infectious Disease Testing Applications
    • 4.2.5 Enhanced Focus On User-Friendly Test Design

5. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Home Care Users
  • 5.4 Public Health Organizations
  • 5.5 Pharmaceutical And Biotechnology Companies

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 9.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Competitive Assay, Sandwich Assay, Multiplex Detection Assay
  • 9.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
  • 9.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
  • 9.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Competitive Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Competitive Assays, Indirect Competitive Assays
  • 9.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Sandwich Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-step Sandwich Assays, Two-step Sandwich Assays
  • 9.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Multiplex Detection Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Multi-analyte Assays, Simultaneous Detection Of Various Targets

10. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

  • 10.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 11.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 12.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 13.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 14.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 15.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 16.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 17.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 18.1. Taiwan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 19.1. South East Asia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 20.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 21.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 22.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 23.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 24.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 25.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 26.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 27.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 28.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 29.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 30.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 31.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 32.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 33.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

  • 34.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regulatory and Investment Landscape

36. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

  • 36.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

  • Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH

38. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

40. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market High Potential Countries, Segments and Strategies

  • 40.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer